Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY: GSK )

33.09 -0.66 (-1.96%)
Official Closing Price Updated: 7:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
36 37 Next >
Thursday Market Overview
If you are an IBM shareholder you now own something new Kyndryl. 
Via Talk Markets
Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals
The biopharma's takeover bid has failed to materialize after nearly two weeks. Here's what might be going on. 
Via The Motley Fool
GlaxoSmithKline PLC Sets New Annual-High Share Price
GlaxoSmithKline PLC (NYSE: GSK) traded today at a new 12-month high of $42.71. Approximately 1.8 million shares have changed hands today, as compared to an average 30-day volume... 
Via Benzinga
No Negative Reaction
Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today. 
Via Talk Markets
Earnings Scheduled For October 27, 2021
Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion. • General... 
Via Benzinga
Daily Report: GlaxoSmithKline (GSK)
TalkMarkets Episode VII-6 Monday, 10/11/21 Stockpicker Star GlaxoSithKline (GSK) Healthcare Sector 
Via Talk Markets
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... 
Via Benzinga
GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript
GSK earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
GlaxoSmithKline Drops Research On Otilimab In COVID-19
GlaxoSmithKline Plc (NYSE: GSK), in its Q3 earnings release, revealed that it is stopping the development of otilimab in COVID-19 in patients who are at least 70 years... 
Via Benzinga
Exposures COVID-19
Glaxo Reports Double-Digit Growth In Q3 Pharma, Vaccine Sales, Updates FY21 Guidance
GlaxoSmithKline Plc's (NYSE: GSK) turnover was £9.07 billion in Q3, up 5% Y/Y (actual exchange rate AER), 10% (constant exchange rate CER). Pharmaceuticals... 
Via Benzinga
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M... 
Via Benzinga
GlaxoSmithKline: My Top Value Stock For The Week
GSK, one of the biggest pharmaceuticals companies in the world, is seeing a lot of success with new drugs and plenty more in the pipeline. Better yet for would-be investors, the stock is still very... 
Via Talk Markets
Chinese Growth Level
The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues. 
Via Talk Markets
Can Pfizer and GlaxoSmithKline Beat Johnson & Johnson's RSV Vaccine?
J&J has set a high bar for its rivals. 
Via The Motley Fool
The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies
Companies working on sorely needed Covid treatments are innovating to keep up. 
Via Investor's Business Daily
More Chinese Trouble
A day after the consumer price rise there was another price rise for producer markets. 
Via Talk Markets
Why CureVac Stock Is Tumbling Today
The company is throwing in the towel on its first-generation COVID-19 vaccine candidate. 
Via The Motley Fool
Exposures COVID-19
Winners and Losers of Rising Energy Prices
Bond traders are back to work on Tuesday after taking Monday off for Columbus Day. Bonds are trading higher this morning as yields are falling slightly. Lower yields could pull... 
Via Benzinga
Why Did Ocugen Stock Skyrocket On Monday?
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 8.8% in Monday’s regular trading session and also gained 11.4% in the after-hours session. What... 
Via Benzinga
Biotech Stocks Are Lagging, Is It Time to Rebalance Your Healthcare Portfolio?
You may have seen that biotech stocks have been in a funk. The IBB has broken through the SMA-200 support line near $160 and it holds a perilous perch at $155, up only about 2.5% year-to-date. The IBB... 
Via Talk Markets
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
Via Benzinga
Exposures COVID-19
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
AstraZeneca Plc (NASDAQ: AZN) released top-line data from the TACKLE Phase 3 trial in which its experimental COVID-19 drug has helped cut the risk of severe disease... 
Via Benzinga
Exposures COVID-19
Here's Why 2022 Could Be a Huge Year for GlaxoSmithKline
Another big step in preventing HIV and AIDS has been taken and GlaxoSmithKline is at the forefront. 
Via The Motley Fool
Exposures Product Safety
Perfumes Of Arabia
Downtrends do eventually run out of pessimistic steam, but it can take a while. 
Via Talk Markets
New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in... 
Via FinancialNewsMedia
Exposures COVID-19
Best Pharmaceutical Stocks To Buy In 2021
The global pharmaceutical market has experienced significant growth in recent years. As of end-2020, the total global pharmaceutical market was valued at about 1.27 trillion U.S. dollars. 
Via Talk Markets
Sweet Smell Of Recovery
Markets today saw many reversals of moves by ADR companies in the course of the day, mainly because of macro changes. 
Via Talk Markets
Global Antibiotics Drugs Market: Which Application Willgain the Lion'S Share? with Top Companies Like:Johnson & Johnson, Sanofi-Aventis, Enanta Pharmaceuticals
QY Research has used its tons of research and analysis experience and deeper knowledge to comprehensively study the global Antibiotics Drugs market. This report promises sound market understanding for... 
Via SBWire
Tesla and Merck Give Investors Some Hope
Friday’s rally appears to have lost its momentum over the weekend because stock futures are trading lower before Monday’s open. China’s troubled real estate... 
Via Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
Copyright © 1995-2016 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.